Management Team

Enrique Castellón

Founding Parner

MD Internal Medicine, BA Economics, MPH MSc Health Policy Harvard University, Former Chairman and Founder of the Spanish Drug Agency., National Institute for Cancer Research (CNIO) and National Institute for Cardiovascular Diseases (CNIC). Deputy Minister for Health and Social Services in the region of Madrid . General Director of the Galician Health Services.

Ángel Santos

Managing & Founding Partner

MD Agricultural Engineering. Has developed his career in Spain, the UK and the US in Johnson's Wax and Lilly, in which he has held different leadership positions in general management, strategic and corporate development, M&A, business development and innovation management.

Pablo Cabello

Technical and Scientific Advisor and Founding Partner

Molecular Biologist. Professional experience in the Instituto de Biología Celular. Histopathology services in the Fundación Jiménez Diaz Hospital. 20 years in the Molecular Genetics laboratory of the Hospital Ramón y Cajal.

Manuel Castellón

Founding Partner & Legal Advisor

Lawyer and Economist. Master in Legal Counseling. 25 years of experience as corporate lawyer . Director and certified company counsel in various media companies. Founder of Castellón Abogados.

Joaquín Velasco

Chairman of the Board

Former EY Partner, BA in Economic Sciences by the Universidad Complutense de Madrid and Audit Juror Censor. He joined Ernst & Young in 1979 and his last position was Managing Director of Fiscal and Legal for the countries of the south of Europe.

María Jaraiz

Investor Relations

Lawyer, specialized in Corporate Law. Founding partner of Castellón Abogados in 1995. Responsible for the Department of Investor Relations and Corporate Communications at CRB Inverbio.

Isabel Santamaría

Manager Financial Control and Reporting

Bs Business Administration. Extensive experience in financial management and reporting in venture capital. Accounting, taxation and auditing. Experience in management control and investments. Responsible for the relationship with CNMV and SEPBLAC and communication and compliance with institutional and private investors.